Basic Information
Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial
INFUSION, SOLUTION CONCENTRATE
Regulatory Information
SIN16899P
November 28, 2023
Prescription Only
Therapeutic
INTRAVENOUS
January 24, 2024
June 4, 2025
XA04AA55
Company Information
Active Ingredients
Palonosetron hydrochloride equivalent to Palonosetron
Strength: 0.25 mg/vial
Fosnetupitant Chloride Hydrochloride equivalent to Fosnetupitant
Strength: 235mg/vial
Detailed Information
Contraindications
**4 CONTRAINDICATIONS** Pregnancy
Indication Information
**1 INDICATIONS AND USAGE** AKYNZEO IV is indicated in adults for the: - Prevention of acute and delayed nausea and vomiting associated with highly emetogenic chemotherapy, including cisplatin. - Prevention of acute and delayed nausea and vomiting associated with moderately emetogenic cancer chemotherapy.